Analysts Offer Predictions for Nexeon Medsystems Inc’s FY2017 Earnings (NXNN)

Nexeon Medsystems Inc (OTCMKTS:NXNN) – Investment analysts at Taglich Brothers issued their FY2017 earnings per share (EPS) estimates for Nexeon Medsystems in a note issued to investors on Tuesday. Taglich Brothers analyst H. Halpern expects that the company will post earnings of ($0.14) per share for the year. Taglich Brothers has a “Speculative Buy” rating on the stock. Taglich Brothers also issued estimates for Nexeon Medsystems’ Q4 2017 earnings at ($0.03) EPS, Q1 2018 earnings at ($0.03) EPS, Q2 2018 earnings at ($0.03) EPS, Q3 2018 earnings at ($0.03) EPS, Q4 2018 earnings at ($0.04) EPS and FY2018 earnings at ($0.13) EPS.

Shares of Nexeon Medsystems (OTCMKTS:NXNN) opened at $1.01 on Friday. The firm has a market cap of $27.50 and a P/E ratio of -5.61. Nexeon Medsystems has a one year low of $0.40 and a one year high of $2.50. The company has a quick ratio of 0.98, a current ratio of 1.60 and a debt-to-equity ratio of 0.37.

ILLEGAL ACTIVITY NOTICE: This piece of content was first reported by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are reading this piece of content on another website, it was illegally copied and republished in violation of US and international copyright & trademark laws. The correct version of this piece of content can be viewed at https://www.dispatchtribunal.com/2018/01/14/analysts-offer-predictions-for-nexeon-medsystems-incs-fy2017-earnings-nxnn.html.

About Nexeon Medsystems

Nexeon MedSystems, Inc is a bioelectronics company developing active medical devices for the treatment of cardiovascular disease. The Company’s developing technology solutions device including electronics, software, mechanical engineering, and material science, as well as pharmaceuticals, protein chemistry, and cell biology.

Receive News & Ratings for Nexeon Medsystems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nexeon Medsystems and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply